aebi and ceo dr. ilan morad, say their treatment, which they call mutato (multi-target toxin)

The treatment, which they call MuTaTo, or multi-target toxin, acts as a “cancer antibiotic” and uses a combination of cancer-targeting peptides (amino acid chains) and a toxin that specifically kills cancer cells. Most cancer drugs attack a specific target on, or in the cancer cell, said AEBi CEO Dr. Ilan Morad.

Full Answer

News coverage you can trust

A team of scientists at a biotech company in Israel claimed that they will have a cure for cancer — all cancer — within a year.

Haaretz Weekly Ep. 14

In recent articles in Israel and the United States, Accelerated Evolution Biotechnologies Ltd., or AEBi, which was founded in 2000 from the ITEK Weizmann technology incubator, announced that a new treatment being developed by the company would offer a complete cure for cancer with “no or minimal side-effects at a much lower cost than most other treatments on the market.”.